Skip to content
Screener

Integra LifeSciences IART Q2 2025 earnings

Reported July 31, 2025 · Before market open

Revenue$415.6MBeat by $1.3M
EPS$0.45Beat by $0.02
Revenue estimate$414.3M
EPS estimate$0.43

Next report

Oct 29, 2026 (in a month)
Revenue estimate$416.3M
EPS estimate$0.56

Financials

Q2 2025

Income statement

See full
Revenue$415.6M-0.6%
Gross profit$209.3M-7.3%
Operating income-$512.7M-16,826%
Net income-$484.1M-3,803%
EPS (diluted)-$6.31-3,844%

Balance sheet

See full
Cash & equivalents$217.9M+1.2%
Total debt$1.9B+39.1%
Total equity$1.0B-32.3%
Total assets$3.7B-10.0%

Cash flow

See full
Operating cash flow$8.9M-77.9%
CapEx$20.1M-32.2%
Free cash flow-$11.2M-205%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$922.44M-59.3%
Enterprise value$2.61B-23.7%
P/S0.6×-0.9×

Profitability

See full
Gross margin52.6%-3.4pp
Operating margin-30.9%-34.9pp

Returns & leverage

See full
Debt / equity1.8×+0.9×
Current ratio1.2×-2.2×

Segments

By product

See full
Neurosurgery$209.0M+1.7%
Wound Reconstruction$84.7M-3.4%
Instruments$53.1M-2.7%
ENT$41.9M+0.4%
Private Label$26.9M-6.3%

By geography

See full
Asia Pacific$47.7M+3.9%
Europe$42.6M+4.7%
Rest of World$19.0M—

By segment

See full
Specialty Surgery$304.0M—
Tissue Reconstruction$111.6M—

FAQ

When did Integra LifeSciences report Q2 2025 earnings?
Integra LifeSciences (IART) reported Q2 2025 earnings on July 31, 2025 before market open.
What were Integra LifeSciences's Q2 2025 revenue and EPS?
Integra LifeSciences reported revenue of $415.6M and eps of $0.45 for Q2 2025.
Did Integra LifeSciences beat estimates in Q2 2025?
Revenue beat the consensus estimate of $414.3M by $1.3M. EPS beat the consensus estimate of $0.43 by $0.02.
How did Integra LifeSciences's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.6% from $418.2M a year earlier and eps declined 28.6% from $0.63.
Where can I find Integra LifeSciences's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000917520-25-000069) and the 10-Q periodic report (0000917520-25-000074) directly on SEC EDGAR. The filing index links above go to sec.gov.